|
 The woman had a low number of blood platelets and clots in small and
large vessels, as well as bleeding, it said.
A few similar cases were found in Norway and in the European
Medicines Agency's (EMA) database of drug side effects, Danish
Medicines Agency said.
"It was an unusual course of illness around the death that made the
Danish Medicines Agency react," it said in a statement late on
Sunday.
Norway said on Saturday that three people, all under the age of 50,
who had received the AstraZeneca vaccine were being treated in
hospital for bleeding, blood clots and a low count of blood
platelets, which were labeled "unusual symptoms" by health
authorities.
Denmark, Norway and Iceland said last week they would halt the
introduction of the AstraZeneca vaccine.
[to top of second column] |
 European vaccination programmes
have been upset in the last two weeks by reports
that recipients of the AstraZeneca inoculation
have suffered blood clots.
The European Medicines Agency has said there is
no indication that the events were caused by the
vaccination, a view that was echoed by the World
Health Organization on Friday.
AstraZeneca Plc said on Sunday a review of
safety data of people vaccinated with its
COVID-19 vaccine has shown no evidence of an
increased risk of blood clots.
(Reporting by Jacob Gronholt-Pedersen; editing
by Catherine Evans, Larry King)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
